Stay updated on ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.5.3 to v3.5.4, indicating a new revision in the revision history. This update does not alter the content or behavior of the page.
    Difference
    0.0%
    Check dated 2026-05-14T23:01:25.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.2 to v3.5.3, reflecting a new template release. It does not change the displayed study details or layout for users.
    Difference
    0.0%
    Check dated 2026-04-30T14:11:45.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.5.2 updated from v3.5.0. This appears to be a minor site update with no changes to study records.
    Difference
    0.0%
    Check dated 2026-04-16T10:34:14.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.0. The previous revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T17:44:46.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This indicates a software update rather than substantive content changes on the study page.
    Difference
    0.0%
    Check dated 2026-03-11T14:33:15.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the long funding-status notice and Revision: v3.4.1. The update does not affect the study details or how the page is used.
    Difference
    0.3%
    Check dated 2026-02-11T02:17:31.000Z thumbnail image

Stay in the know with updates to ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.